Hansoh Pharmaceutical Group Company Limited

HKEX:3692.HK

17.7 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Operating Activities:
Net Income 2,725.5251,988.6551,288.8481,285.7711,297.9761,422.3121,290.591,347.0731,221.8341,260.7051,296.037860.7411,042.307475.762398.868398.868398.868369.009369.009369.009
Depreciation & Amortization 216.767181.503184.878186.435158.167146.331132.136120.867107.36396.67192.8978.93769.68739.77434.50334.50334.50330.32630.32630.326
Deferred Income Tax 00-183.557376.224-605.143553.542.122603.14895.68300000000000
Stock Based Compensation 67.58785.1486.225128.22251.19423.38342.08951.50917.08100000000000
Change In Working Capital 177.194271.41530.976-599.411316.767-19.451-359.387-514.864211.965571.298222.956432.114-530.787-10.965-103.239-103.239-103.239-89.62-89.62-89.62
Accounts Receivables 268.89396.21245.548-550.814641.26-496.109-53.238-745.914-135.278582.264-182.013160.388-615.6440000000
Change In Inventory -30.48918.679-148.21646.368-87.311-80.774-30.97391.25722.514-0.15257.47927.523-60.638-8.279-19.599-19.599-19.599-23.755-23.755-23.755
Change In Accounts Payables 00000000000-193.7812.6860000000
Other Working Capital -61.21156.526-66.356-94.965-237.182557.432-275.176139.793324.729-10.814347.49244.203145.495-2.686-83.639-83.639-83.639-65.865-65.865-65.865
Other Non Cash Items -504.69-556.412-444.76-33.654-50.262-79.652-21.28924.433-196.782-77.341-133.5273.763115.46513.48520.4320.4320.431.9131.9131.913
Operating Cash Flow 2,682.3831,970.3011,146.167967.3631,773.8421,492.9231,084.1391,029.0181,361.4611,851.3331,478.3561,375.555696.672518.057350.563350.563350.563311.627311.627311.627
Investing Activities:
Investments In Property Plant And Equipment -101.846-126.96-92.638-86.907-185.914-207.702-252.331-1,124.46-303.185-305.149-287.327-235.925-145.453-101.804-65.772-65.772-65.772-68.372-68.372-68.372
Acquisitions Net 000000000001,649.221247.6150000000
Purchases Of Investments 00000000000-1,664.605-2,811.958-2,811.958-1,186.186-1,186.186-1,186.186-1,193.284-1,193.284-1,193.284
Sales Maturities Of Investments 0000000000015.3842,564.3432,564.3431,097.5391,097.5391,097.5391,464.2871,464.2871,464.287
Other Investing Activites 2,470.715159.061,134.51-379.806-5,282.446-2,472.607673.4834,303.439-5,749.9212,631.027-9,114.15-482.402-524.964349.419154.418154.418154.418-202.631-202.631-202.631
Investing Cash Flow 2,368.86932.11,041.872-466.713-5,468.36-2,680.309421.1523,178.979-6,053.1062,325.878-9,401.477-718.327-670.417-349.419-154.418-154.418-154.418202.631202.631202.631
Financing Activities:
Debt Repayment -4,192.6150-8.9920-7.4670-3,844.820-3.3030-39.311000000-112.5-112.5-112.5
Common Stock Issued 000000000002,383.59900000325.612325.612325.612
Common Stock Repurchased -33.693-35.411-79.454-18.558-58.06-57.96900000000000000
Dividends Paid 0-652.0820-712.1840-316.53-64.336-2,000-2,200-900-600-37500-101.034-101.034-101.034-592.127-592.127-592.127
Other Financing Activities 29.979-15.74337.987-32.57310.698-4.3215.111-4.2983,171.973928.4578,603.582-2,008.59900101.034101.034101.034379.015379.015379.015
Financing Cash Flow -4,196.329-703.236-50.459-763.315-54.829-378.8193,795.595-2,004.298968.6728.4577,964.2712,008.599266.4440-182.619-182.619-182.619-611.285-611.285-611.285
Other Information:
Effect Of Forex Changes On Cash -39.232-49.987-72.377221.27-261.835-368.082288.794-812.25449.987118.45214.75814.7870.11700.910.910.91108.905108.905108.905
Net Change In Cash 815.69102,065.203-41.395-4,011.182-1,934.2875,589.681,391.445-3,672.9884,324.1255.9081,043.399226.205174.59714.43614.43614.43611.87711.87711.877
Cash At End Of Period 6,796.2044,731.3354,731.3352,666.1322,707.5276,718.7098,652.9963,063.3161,671.8715,344.8591,020.7391,336.215292.816241.20866.61166.61166.61152.17552.17552.175